Dr. Paul Orchard is the Medical Director of the Inherited Metabolic and Storage Disease Program and a Professor in the Department of Pediatrics, Division of Blood and Marrow Transplant & Cellular Therapy. Dr. Orchard’s focus is in the use of hematopoietic stem cell transplantation and other cell therapies for inherited metabolic disorders, with a special interest in the inherited Leukodystrophies, the Mucopolysaccharidoses and Osteopetrosis. His clinical research is in evolving new and combination therapies to decrease toxicity and improve outcomes, with a particular interest in the use of gene therapy approaches.

Dr. Paul Orchard completed his MD from Brown University Hospital, Residency in Pediatrics from University of Wisconsin Hospital, and Fellowship in Hematology-Oncology and Blood and Marrow Transplantation from the University of Minnesota Medical School. He serves as the Director of Mucopolysaccharidosis (MPS) Center, University of Minnesota.

Representative Publications:

Differences in MPS I and MPS II Disease Manifestations

Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement

Treatment of Brain Disease in the Mucopolysaccharidoses

Unique Medical Issues in Adult Patients With Mucopolysaccharidoses

Share

Discuss in Social Wall

Share to rareTeam

Bookmark